Psychedelic Stock Gainers And Losers From January 18, 2022
GAINERS:
Cybin (AMEX:CYBN) shares closed up 1.90% at $1.07
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 445 companies made new 52-week lows.
Seelos Therapeutics Shares Spike Higher; Co Confirms Earlier Report To Acquire Exclusive License Of iX Biopharma’s Proprietary Wafer-Based Delivery Platform For Sublingual Ketamine For Upfront Fee Of $9M
Seelos plans to evaluate sublingual ketamine, now named SLS-003, in pain indications such as chronic neuropathic pain and Complex Regional Pain Syndrome (CRPS) and in additional psychiatric disorders, including
IX Biopharma Says Entered Exclusive License Agreement With Seelos Therapeutics for Wafermine and Other Sublingual Ketamine Wafer Products; iX Biopharma to Receive a $9M Upfront Plus Up to $239M in Milestone Payments Plus Royalties
iX Biopharma Ltd (SGX:42C), a specialty pharmaceutical company that develops innovative therapies using its proprietary sublingual drug delivery technology, WaferiX, announced today that it has, through its subsidiary, entered into an exclusive license agreement with Seelos Therapeutics, Inc ("Seelos") (Nasdaq: SEEL), a compan
Seelos Therapeutics To Test Trehalose In Patients With Rare Movement Control Disorder
The FDA has accepted Seelos Therapeutics Inc’s (NASDAQ:SEEL) Investigation New Drug application to study SLS-005 (trehalose injection, 90.5 mg/mL) for spinocerebellar…
Seelos Therapeutics Presents Poster On SLS-002 (Intranasal Racemic Ketamine) At 2021 IASR/AFSP International Summit On Suicide Research
Seelos Therapeutics, Inc. (NASDAQ:SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today presented a poster on Part 1, the
‘3 Biotech Penny Stocks to Watch That Are Climbing Right Now’ -Pennystocks.com Article
https://pennystocks.com/featured/2021/10/22/3-biotech-penny-stocks-watch-climbing-now/
